Open Access Articles- Top Results for Valve replacement
General Medicine: Open AccessPersistent Left Superior Vena Cava during Aortic Valve Replacement
Journal of Cardiovascular Diseases & DiagnosisRight Parasternal Cardiac Surgery after Radical Treatment of Left Breast Cancer
Journal of Medical Diagnostic MethodsUse of Supine Bicycle Stress Echocardiography in Quantitating Right Ventricular Reserve and Exercise Capacity in Adults with Repaired Tetralogy of Fal
Journal of Clinical & Experimental CardiologyMultiparametric Assessment of Post-Transcatheter Aortic Valve Repacement Paravalvular Regurgitation Grading by Transthoracic Echocardiography and Car
Journal of Clinical & Experimental CardiologyTranscatheter Aortic Valve Replacement
|This article needs additional citations for verification. (October 2013)|
Valve replacement surgery is the replacement of one or more of the heart valves with either an artificial heart valve or a bioprosthesis (homograft from human tissue or xenograft e.g. from pig). It is an alternative to valve repair.
There are four procedures
- Aortic valve replacement
- Mitral valve replacement
- Tricuspid valve replacement
- Pulmonary valve replacement
Current aortic valve replacement approaches include closed heart surgery, Very invasive cardiac surgery (VICS) and Very invasive, Scapulae-based aortic valve replacement.
Catheter replacement of the aortic valve (called trans-aortic valve replacement or implementation [TAVR or TAVI]) is a minimally invasive option for those suffering from aortic valve stenosis. TAVR is commonly performed by guiding a catheter from the groin to the narrowed valve via the aorta using realtime x-ray technology. A metal stent containing a valve is then deployed using a balloon to press the stent into the valve in effect opening the stenosed (or narrowed) valve and lodging the stent in place. The procedure was first approved in the United States in November 2011  as an alternative for people deemed a poor candidate for open approach replacement; however, TAVR has been successfully implemented into practice in other countries prior to 2011.
In those between 50 and 70 years of age bioprosthetic and mechanical aortic valves have similar overall outcomes with respect to stroke and survival.
- "FDA-approved transcatheter approach offers life-extending valve replacement for inoperable patients". Stanford School of Medicine. Retrieved 19 July 2013.
- Chiang, Yuting P.; Chikwe, Joanna; Moskowitz, Alan J.; Itagaki, Shinobu; Adams, David H.; Egorova, Natalia N. (1 October 2014). "Survival and Long-term Outcomes Following Bioprosthetic vs Mechanical Aortic Valve Replacement in Patients Aged 50 to 69 Years". JAMA 312 (13): 1323. doi:10.1001/jama.2014.12679.
- ValveReplacement.org An online support forum.